Skip to main content

Table 1 Allocation of patients according to suPAR below or above median

From: The prognostic value of the suPARnostic®ELISA in HIV-1 infected individuals is not affected by uPAR promoter polymorphisms

  Low suPAR < 4.67 ng/mL (N = 40) High suPAR ≥ 4.67 ng/mL (N = 41) Low vs high P (Mann-Whitney U test)
suPAR (ng/ml)* 3,23 (1.22–4.65) 6.96 (4.67–12.16)  
Gender (M/F) 34/6 31/10 NS
Eci-1:    
G/G 24 23 NS
G/A 4 5  
A/A 0 0  
MspA1 l    
A/A 21 16 NS
A/G 6 10  
G/G 1 2  
Age at suPAR meas. (years)* 28.5 (18.8–42.9) 34.5 (19.9–78.2) < 0.001
Time from seroconversion to suPAR meas. (years)* 0.42 (0.0–4.55) 0.47 (0.0–5.72) NS
Death within 2 years (Y/N) 0/40 13/28 < 0.001
Median (range) follow-up (years) from sample to 15th May 1996* 5.94 (0.21 – 13.63) 5.38 (0.35 – 10.68) NS
Death before 15th May 1996 (Y/N) 17/23 25/16 NS
  1. *Median (range). N = number, M/F = Male/Female, NS = non-significant, Y/N = Yes/No